Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Leukemia 26Lymphoma 19Leukemia, Myeloid, Acute 19Myelodysplastic Syndromes 16Burkitt Lymphoma 15Lymphoma, Non-Hodgkin 12Lymphoma, Follicular 12Recurrence 11Leukemia, Lymphocytic, Chronic, B-Cell 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, Large B-Cell, Diffuse 9Hodgkin Disease 9Graft vs Host Disease 9Leukemia, Myelomonocytic, Chronic 8Leukemia, Myeloid, Accelerated Phase 8Lymphoma, Mantle-Cell 7Leukemia, Myeloid, Chronic-Phase 7Multiple Myeloma 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Myelomonocytic, Juvenile 6Congenital Abnormalities 6Breast Neoplasms 6Blast Crisis 6Neoplasms, Plasma Cell 5Myeloproliferative Disorders 5Myelodysplastic-Myeloproliferative Diseases 5Lymphoma, Large-Cell, Immunoblastic 5Dendritic Cell Sarcoma, Interdigitating 5Urinary Bladder Neoplasms 4

Interventions

dexamethasone acetate 1dexamethasone 21-phosphate 1asparaginase erwinia chrysanthemi recombinant 1ZD4054 1Vincristine 1Paclitaxel 1Methotrexate 1Doxorubicin 1Dexrazoxane 1Dexamethasone 1Cytarabine 1Carboplatin 1Calcium Dobesilate 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Hypersensitivity × Methotrexate × Clear all
NCT00928200 2019-02-19

Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224)

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1 Terminated
1 enrolled 7 charts
LymphoidOther hematologic neoplasm

Hypersensitivity, Leukemia, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡